30 August 2019

Walgreens Mobilizes in Advance of Hurricane Dorian to Support Customers, Team Members and Communities in Storm’s Projected Path

Walgreens is taking proactive measures to assist customers, team members and communities in the projected path of Hurricane Dorian, and is preparing to fully support impacted regions in the storm’s aftermath.
19 August 2019

Kroger and Walgreens to Expand Exploratory Pilot to Knoxville, Tennessee

CINCINNATI, OH, and DEERFIELD, IL, Aug. 19, 2019 – Building on an exploratory pilot launched in October 2018, The Kroger Co. and Walgreens today announced the introduction of a new test area for the retailers, featuring the expansion of Kroger Express and Kroger Pickup at select Walgreens stores as well as the launch of Walgreens’ owned-brand health and beauty products in 17 Kroger stores in Knoxville, Tennessee.  

01 August 2019

Bausch Health Expands Dermatology Cash-Pay Prescription Program To Walgreens Stores Nationwide

DEERFIELD, Ill., and LAVAL, Quebec  – August 1, 2019 – Walgreens and Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") today announced a modification to their existing fulfillment agreement to bring patients lower prices, increased transparency and convenience for many of
Bausch Health’s dermatology products. Under the expanded agreement, Walgreens patients will have access to select dermatology products from Bausch Health’s first-of-its-kind cash-pay prescription program, Dermatology.com, at lower flat cash rates ranging from $50-$115. The program was launched under its Ortho Dermatologics business in March 2019, and will be available at more than 9,500 Walgreens U.S. retail pharmacy locations by the end of August 2019.
30 July 2019

Shields Health Solutions Receives Equity Investments from Welsh, Carson, Anderson & Stowe and Walgreen Co.

STOUGHTON, MASS., NEW YORK, NY, and DEERFIELD, ILL. – July 31, 2019 – Shields Health Solutions, Welsh, Carson, Anderson & Stowe (“WCAS”) and Walgreen Co. (“Walgreens”) today announced the parties have entered into a definitive agreement through which WCAS and Walgreens will make equity investments in Shields. Terms of the agreement were not disclosed.
30 July 2019

Humana and Walgreens to Open Additional In-store Partners in Primary Care Centers

LOUISVILLE, Ky. & DEERFIELD, Ill. July 30, 2019 Humana and Walgreens are expanding their existing senior-focused neighborhood health collaboration that brings together full service primary care, pharmacy, nutrition and wellness support and other services for Medicare beneficiaries. The companies announced today that they plan to open three additional Partners in Primary Care centers inside Walgreens stores – two in the Kansas City area and another in Anderson, SC. 
 
22 July 2019

Walgreens Find Care™ Platform Introduces Chronic Care Management for Patients with Diabetes, Asthma and COPD

DEERFIELD, Ill., July 22, 2019 - Walgreens today announced that it has expanded the Walgreens Find Care platform to now include chronic care management, featuring connected devices and digital therapeutic solutions for patients with diabetes, asthma and chronic obstructive pulmonary disease (COPD). In addition, one year since launch, several new health care offerings from existing and new partners have been added to the platform.
18 July 2019

Walgreens Earns Best Place to Work in 2019 Disability Equality Index

Walgreens for the third consecutive year has been recognized with the top-score of 100 percent on the 2019 Disability Equality Index® (DEI), a national benchmarking tool on corporate policies and practices related to disability inclusion and workplace equality.
12 July 2019

Walgreens Mobilizes in Advance of Tropical Storm Barry to Support Customers, Team Members and Communities in Storm’s Projected Path

Walgreens is taking proactive measures to assist customers, team members and communities currently in the projected path of Tropical Storm Barry, and is preparing to fully support any impacted regions in its aftermath.
11 July 2019

Walgreens and Kaléo Expand Retail Pharmacy Collaboration to Include AUVI-q® (epinephrine injection, USP) 0.1 mg, the Only FDA-Approved Epinephrine Auto-Injector for Infants and Toddlers, 16.5 – 33 lbs

Walgreens and kaléo, a privately-held pharmaceutical company, today announced AUVI-q® (epinephrine injection, USP) 0.1 mg auto-injector is available at Walgreens locations nationwide. AUVI-q 0.1 mg is the first and only epinephrine auto-injector (EAI) approved by the U.S. Food and Drug Administration (FDA) for infants and toddlers weighing 16.5 to 33 pounds (7.5 to 15 kilograms). Through this collaboration, Walgreens is the first national retail pharmacy to offer the entire AUVI-Q auto-injector product line, which also includes AUVI-Q 0.3 mg and 0.15 mg doses.